ZTOX Insights

RELAXO

RELAXO

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Relaxo Footwears (RELAXO): Company Update

Company Update Intimation under Regulation 30 of SEBI (LODR) Regulations 2015 - Investment upto Rs 2.50 Crore by way of subscription to and/or acquisition of equity shares carrying voting rights in a Special Purpose Vehicle. Intimation under Regulation 30 of SEBI (LODR) Regulations 2015 - Investment upto Rs 2.50 Crore by way of subscription to and/or acquisition of equity shares carrying voting rights in a Special Purpose Vehicle.

Read article

RENUKA

RENUKA

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Shree Renuka Sugars (RENUKA): Arrangements for strategic, technical, manufacturing, or marketing tie up

Arrangements for strategic, technical, manufacturing, or marketing tie up Shree Renuka Sugars Limited has informed the Exchange about Arrangements for strategic, technical, manufacturing, or marketing tie up - Execution of definitive agreements for marketing and distribution of sugar under the Madhur Brand Shree Renuka Sugars Limited has informed the Exchange about Arrangements for strategic, technical, manufacturing, or marketing tie up - Execution of definitive agreements for marketing and

Read article

HINDCOPPER

HINDCOPPER

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Hindustan Copper (HINDCOPPER): Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company Hindustan Copper Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company Hindustan Copper Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

Read article

AWL

AWL

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

AWL Agri Business (AWL): Company Update

Company Update Disclosure under Regulation 30 of SEBI Listing Regulations.- Execution of definitive agreements for marketing and distribution of sugar under "Madhur" brand Disclosure under Regulation 30 of SEBI Listing Regulations.- Execution of definitive agreements for marketing and distribution of sugar under "Madhur" brand Disclosure under Regulation 30 of SEBI Listing Regulations.- Execution of definitive agreements for marketing and distribution of sugar under "Madhur" brand

Read article

RENUKA

RENUKA

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Shree Renuka Sugars (RENUKA): Company Update

Company Update Execution of definitive agreements for marketing and distribution of sugar under the "Madhur" Brand Execution of definitive agreements for marketing and distribution of sugar under the "Madhur" Brand

Read article

ZYDUSLIFE

ZYDUSLIFE

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Zydus Lifesciences (ZYDUSLIFE): Company Update

Company Update Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA. Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA. Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA.

Read article

ECOSMOBLTY

ECOSMOBLTY

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

ECOS (India) Mobility & Hospitality (ECOSMOBLTY): Board Meeting

Board Meeting 1. Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended March 31, 2026, we submit herewith: a) the Auditor's Report on Standalone & Consolidated Financial Results issued by our Statutory Auditors M/s SS Kothari Mehta & Co. LLP, Chartered Accounts b) Audited Financial Results (Standalone & Consolidated) for the quarter and year ended March 31, 2026 c) Audited Statement of Assets and Liabilities as on March 31, 2026 d)

Read article

ZYDUSLIFE

ZYDUSLIFE

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Zydus Lifesciences (ZYDUSLIFE): Press Release

Press Release Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA". Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority

Read article

TCIEXP

TCIEXP

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

TCI Express Releases Q4/FY 2025-26 Investor Presentation on BSE

TCI Express has made its Q4/FY 2025-26 investor presentation available through BSE, offering stakeholders insight into the company's latest quarterly performance and financial positioning.

Read article

TCIEXP

TCIEXP

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

TCI Express Q4 FY 2025-26 Investor Presentation Published on BSE

TCI Express has published its Q4/FY 2025-26 investor presentation on BSE, offering stakeholders a detailed overview of the company's quarterly performance and financial position.

Read article

GPPL

GPPL

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Gujarat Pipavav Port Files Investor Presentation with NSE

Gujarat Pipavav Port Limited has informed the NSE about filing an investor presentation, providing stakeholders with updates on company performance and strategy.

Read article

ANUHPHR

ANUHPHR

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Anuh Pharma Submits Investor Presentation to NSE

Anuh Pharma Limited has submitted an investor presentation to the National Stock Exchange, marking a routine corporate disclosure. The filing aligns with standard regulatory requirements for listed entities.

Read article

GEL

GEL

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Gautam Exim (GEL) Fixes 3:1 Bonus Issue Record Date: June 10, 2026

Gautam Exim (GEL) has announced a 3:1 bonus issue with June 10, 2026 as the record date, entitling every existing shareholder to receive three additional shares for every one held.

Read article